MedDataX Logo

Prostaglandins Before Caserean Section

NCT ID: NCT03366259

Last Updated: 2017-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-31

Study Completion Date

2018-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study is to assess the value of administration of prostaglandins before cesarean section to reduce the amount of blood loss

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

160 full term pregnant patients candidate for elective cesarean section were randomly allocated into 2 groups ,80 patients will receive 200mcg of rectal prostaglandins before cesarean section and 80 patients are used as control receiving placebo

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrapartum Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A (Misoprostol group)

200 mcg rectal Misoprostol administration before cesarean section

Group Type ACTIVE_COMPARATOR

Misoprostol 200Mcg Tab

Intervention Type DRUG

administration of 200 Mcg of misoprotol rectal

elective cesarean section

Intervention Type PROCEDURE

elective cesarean section for full term patients

Group B (control group)

No prostaglandins administration before cesarean section

Group Type PLACEBO_COMPARATOR

elective cesarean section

Intervention Type PROCEDURE

elective cesarean section for full term patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Misoprostol 200Mcg Tab

administration of 200 Mcg of misoprotol rectal

Intervention Type DRUG

elective cesarean section

elective cesarean section for full term patients

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\-

Exclusion Criteria

* medical disorder with pregnancy
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

sarah mohamed hassan

lecturer of obstetrics and gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr El Ainiy Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4122017

Identifier Type: -

Identifier Source: org_study_id